WO2002026826A3 - Proteins and nucleic acids encoding same - Google Patents

Proteins and nucleic acids encoding same Download PDF

Info

Publication number
WO2002026826A3
WO2002026826A3 PCT/US2001/042336 US0142336W WO0226826A3 WO 2002026826 A3 WO2002026826 A3 WO 2002026826A3 US 0142336 W US0142336 W US 0142336W WO 0226826 A3 WO0226826 A3 WO 0226826A3
Authority
WO
WIPO (PCT)
Prior art keywords
proteins
nucleic acids
acids encoding
encoding same
disclosed
Prior art date
Application number
PCT/US2001/042336
Other languages
French (fr)
Other versions
WO2002026826A2 (en
Inventor
Valerie L Gerlach
John R Macdougall
Glennda Smithson
Isabelle Millet
David Stone
Erik Gunther
Karen Ellerman
William M Grosse
John P Ii Alsobrook
Denise M Lepley
Catherine E Burgess
Muralidhara Padigaru
Ramesha Kekuda
Kimberly A Spytek
Martin D Leach
Richard A Shimkets
Original Assignee
Curagen Corp
Valerie L Gerlach
John R Macdougall
Glennda Smithson
Isabelle Millet
David Stone
Erik Gunther
Karen Ellerman
William M Grosse
John P Ii Alsobrook
Denise M Lepley
Catherine E Burgess
Muralidhara Padigaru
Ramesha Kekuda
Kimberly A Spytek
Martin D Leach
Richard A Shimkets
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to AU1181802A priority Critical patent/AU1181802A/en
Priority claimed from US09/964,956 external-priority patent/US6875570B2/en
Application filed by Curagen Corp, Valerie L Gerlach, John R Macdougall, Glennda Smithson, Isabelle Millet, David Stone, Erik Gunther, Karen Ellerman, William M Grosse, John P Ii Alsobrook, Denise M Lepley, Catherine E Burgess, Muralidhara Padigaru, Ramesha Kekuda, Kimberly A Spytek, Martin D Leach, Richard A Shimkets filed Critical Curagen Corp
Priority to EP01979901A priority patent/EP1373313A2/en
Priority to JP2002531208A priority patent/JP2004527222A/en
Priority to CA002422891A priority patent/CA2422891A1/en
Publication of WO2002026826A2 publication Critical patent/WO2002026826A2/en
Publication of WO2002026826A3 publication Critical patent/WO2002026826A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antiboides, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
PCT/US2001/042336 2000-09-27 2001-09-27 Proteins and nucleic acids encoding same WO2002026826A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU1181802A AU1181802A (en) 2000-09-27 2001-09-26 Novel proteins and nucleic acids encoding same
EP01979901A EP1373313A2 (en) 2000-09-27 2001-09-27 Proteins and nucleic acids encoding same
JP2002531208A JP2004527222A (en) 2000-09-27 2001-09-27 Novel proteins and nucleic acids encoding them
CA002422891A CA2422891A1 (en) 2000-09-27 2001-09-27 Novel proteins and nucleic acids encoding same

Applications Claiming Priority (31)

Application Number Priority Date Filing Date Title
US23606600P 2000-09-27 2000-09-27
US23563300P 2000-09-27 2000-09-27
US23606500P 2000-09-27 2000-09-27
US23606400P 2000-09-27 2000-09-27
US23580800P 2000-09-27 2000-09-27
US23563100P 2000-09-27 2000-09-27
US60/235,633 2000-09-27
US60/236,066 2000-09-27
US60/236,064 2000-09-27
US60/235,631 2000-09-27
US60/235,808 2000-09-27
US60/236,065 2000-09-27
US23613500P 2000-09-28 2000-09-28
US60/236,135 2000-09-28
US23743400P 2000-10-03 2000-10-03
US60/237,434 2000-10-03
US23832100P 2000-10-05 2000-10-05
US60/238,321 2000-10-05
US23839900P 2000-10-06 2000-10-06
US27639600P 2000-10-06 2000-10-06
US23839600P 2000-10-06 2000-10-06
US60/238,396 2000-10-06
US60/238,399 2000-10-06
US27666701P 2001-03-16 2001-03-16
US60/276,667 2001-03-16
US29482301P 2001-05-31 2001-05-31
US60/294,823 2001-05-31
US30486801P 2001-07-12 2001-07-12
US60/304,868 2001-07-12
US09/964,956 2001-09-26
US09/964,956 US6875570B2 (en) 2000-09-27 2001-09-26 Proteins and nucleic acids encoding same

Publications (2)

Publication Number Publication Date
WO2002026826A2 WO2002026826A2 (en) 2002-04-04
WO2002026826A3 true WO2002026826A3 (en) 2003-10-30

Family

ID=29255797

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/042336 WO2002026826A2 (en) 2000-09-27 2001-09-27 Proteins and nucleic acids encoding same

Country Status (1)

Country Link
WO (1) WO2002026826A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2281437T3 (en) 2000-08-22 2007-10-01 Agensys, Inc. NUCLEIC ACID AND CORRESPONDING PROTEIN DENOMINATED 158P1D7 USEFUL FOR THE TREATMENT AND DETECTION OF BLADDER CANCER AND OTHER CANCERES.
US7358353B2 (en) 2000-08-22 2008-04-15 Agensys, Inc. Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
US6638745B1 (en) * 2001-03-13 2003-10-28 Applera Corporation Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
EP1576099A4 (en) 2002-04-12 2007-07-11 Bristol Myers Squibb Co Novel polynucleotides encoding the human citron kinase polypeptide, bmsnkc 0020/0021
JP2007524361A (en) * 2003-02-10 2007-08-30 アジェンシス， インコーポレイテッド 158P1D7 nucleic acid and corresponding protein useful for the treatment and detection of bladder cancer and other cancers
AU2013305534B2 (en) 2012-08-23 2018-05-31 Agensys, Inc. Antibody drug conjugates (ADC) that bind to 158P1D7 proteins

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990000569A1 (en) * 1988-07-15 1990-01-25 Central Sydney Area Health Service Acid-labile subunit (als) of insulin-like-growth factor (igf) binding protein complex
WO2001081363A1 (en) * 2000-04-27 2001-11-01 Smithkline Beecham Corporation Novel compounds
WO2002016593A2 (en) * 2000-08-22 2002-02-28 Agensys, Inc. Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
WO2002029038A2 (en) * 2000-10-04 2002-04-11 Curagen Corporation Novel proteins and nucleic acids encoding same and antibodies directed against these proteins

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990000569A1 (en) * 1988-07-15 1990-01-25 Central Sydney Area Health Service Acid-labile subunit (als) of insulin-like-growth factor (igf) binding protein complex
WO2001081363A1 (en) * 2000-04-27 2001-11-01 Smithkline Beecham Corporation Novel compounds
WO2002016593A2 (en) * 2000-08-22 2002-02-28 Agensys, Inc. Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
WO2002029038A2 (en) * 2000-10-04 2002-04-11 Curagen Corporation Novel proteins and nucleic acids encoding same and antibodies directed against these proteins

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE EBI [online] 18 February 2000 (2000-02-18), XP002215668, Database accession no. AL137517 *
JANOSI J.B.M. ET AL.: "The acid-labile subunit of the serum insulin-like growth factor-binding protein complexes", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 274, no. 33, 13 August 1999 (1999-08-13), pages 23328 - 23332, XP002215667 *

Also Published As

Publication number Publication date
WO2002026826A2 (en) 2002-04-04

Similar Documents

Publication Publication Date Title
WO2002006339A3 (en) Proteins and nucleic acids encoding same
WO2002014368A8 (en) Proteins and nucleic acids encoding the same
WO2002055705A3 (en) Proteins and nucleic acids encoding same
WO2002064791A3 (en) Proteins and nucleic acids encoding same
WO2002050277A3 (en) Protein and nucleic acids encoding same
WO2002057453A3 (en) Polypetides and nucleic acids encoding same
WO2002068649A3 (en) Proteins and nucleic acids encoding same
WO2002057450A3 (en) Proteins and nucleic acids encoding same
WO2002081518A3 (en) Proteins, polynucleotides encoding them and methods of using the same
WO2001060990A3 (en) Sphingosine kinases
WO2001090155A3 (en) Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
WO2002029058A3 (en) Human proteins, polynucleotides encoding them and methods of using the same
WO2002098917A3 (en) Human proteins and nucleic acids encoding same
WO2001081578A3 (en) Novel proteins and nucleic acids encoding same
WO2004015060A3 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2002068652A3 (en) Nov-x proteins and nucleic acids encoding same
WO2002016599A3 (en) Proteins and nucleic acids encoding same
WO2002029038A3 (en) Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
WO2002055704A3 (en) Proteins, polynucleotides encoding them and methods of using the same
WO2002010216A3 (en) Proteins and nucleic acids encoding same
WO2002055702A3 (en) Human proteins, polynucleotides encoding them and methods of using the same
WO2002081510A3 (en) Proteins, polynucleotides encoding them and methods of using the same
WO2002046229A3 (en) Novel proteins and nucleic acids encoding same
WO2002066643A3 (en) Proteins, polynucleotides encoding them and methods of using the same
WO2001066747A3 (en) Proteins named fctrx and nucleic acids encoding same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US US US US US US US US US US US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2422891

Country of ref document: CA

Ref document number: 2002211818

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2002531208

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2001979901

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2001979901

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001979901

Country of ref document: EP